Your browser doesn't support javascript.
loading
Effect of Optimized Immunosuppression (Including Rituximab) on Anti-Donor Alloresponses in Patients With Chronically Rejecting Renal Allografts.
Shiu, Kin Yee; Stringer, Dominic; McLaughlin, Laura; Shaw, Olivia; Brookes, Paul; Burton, Hannah; Wilkinson, Hannah; Douthwaite, Harriet; Tsui, Tjir-Li; Mclean, Adam; Hilton, Rachel; Griffin, Sian; Geddes, Colin; Ball, Simon; Baker, Richard; Roufosse, Candice; Horsfield, Catherine; Dorling, Anthony.
Afiliação
  • Shiu KY; Department of Inflammation Biology, MRC Centre for Transplantation, Guy's Hospital, King's College London, London, United Kingdom.
  • Stringer D; Biostatistics and Health Informatics, The Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • McLaughlin L; Department of Inflammation Biology, MRC Centre for Transplantation, Guy's Hospital, King's College London, London, United Kingdom.
  • Shaw O; Viapath Analytics LLP, London, United Kingdom.
  • Brookes P; Histocompatibility and Immunogenetics, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Burton H; Department of Inflammation Biology, MRC Centre for Transplantation, Guy's Hospital, King's College London, London, United Kingdom.
  • Wilkinson H; Department of Inflammation Biology, MRC Centre for Transplantation, Guy's Hospital, King's College London, London, United Kingdom.
  • Douthwaite H; Department of Inflammation Biology, MRC Centre for Transplantation, Guy's Hospital, King's College London, London, United Kingdom.
  • Tsui TL; Department of Inflammation Biology, MRC Centre for Transplantation, Guy's Hospital, King's College London, London, United Kingdom.
  • Mclean A; Imperial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Hilton R; Department of Nephrology and Transplantation, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
  • Griffin S; Department of Nephrology, University Hospital of Wales, Cardiff, United Kingdom.
  • Geddes C; Renal Unit, Western Infirmary, NHS Greater Glasgow and Clyde Trust, Glasgow, United Kingdom.
  • Ball S; Department of Nephrology, University Hospital Birmingham, Birmingham, United Kingdom.
  • Baker R; Renal Unit, St. James's University Hospital, Leeds, United Kingdom.
  • Roufosse C; Histocompatibility and Immunogenetics, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Horsfield C; Department of Histopathology, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
  • Dorling A; Department of Inflammation Biology, MRC Centre for Transplantation, Guy's Hospital, King's College London, London, United Kingdom.
Front Immunol ; 11: 79, 2020.
Article em En | MEDLINE | ID: mdl-32117242
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia de Imunossupressão / Transplante de Rim / Rituximab / Rejeição de Enxerto / Sobrevivência de Enxerto / Imunossupressores Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia de Imunossupressão / Transplante de Rim / Rituximab / Rejeição de Enxerto / Sobrevivência de Enxerto / Imunossupressores Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article